Identification of candidate microbial sequences from inflammatory lesion of giant cell arteritis

Clinical Immunology

Volumn 111, Issue 3, 2004, Pages 286-296

  Gordon, Lynn K ^a   Goldman, Melissa ^c   Sandusky, Hallie ^a   Ziv, Nurit ^c   Hoffman, Gary S ^d   Goodglick, Todd ^e   Goodglick, Lee ^b,c,e  

^a JULES STEIN EYE INSTITUTE   (United States)

^b Dept of Pathol and Lab Medicine ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

Author keywords

Aging; Giant cell arteritis; Granulomatous inflammation; Laser capture microdissection; Representational difference analysis; Temporal arteritis; Vasculitis

Indexed keywords

DNA FRAGMENT; IMMUNOGLOBULIN G;

AMINO ACID SEQUENCE; ARTICLE; ASSAY; CELL ISOLATION; CONTROLLED STUDY; GENE IDENTIFICATION; GENE ISOLATION; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LASER MICROSCOPY; MICROBIAL GENETICS; MICROBIAL IDENTIFICATION; MOLECULAR CLONING; PATHOGENESIS; PRIORITY JOURNAL; PROKARYOTE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TEMPORAL ARTERY;

AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CLONING, MOLECULAR; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION; LASERS; MICRODISSECTION; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TEMPORAL ARTERIES; TEMPORAL ARTERITIS;

EID: 2942536378     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2003.12.016     Document Type: Article

References (61)

1. Hayreh S.S., Podhajsky P.A., Zimmerman B. Ocular manifestations of giant cell arteritis. Am. J. Ophthalmol. 125(4):1998;509-520
2. Gordon L.K., Levin L.A. Visual loss in giant cell arteritis. JAMA. 280(4):1998;385-386
3. Hunder G.G., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 33(8):1990;1122-1128
4. Weyand C.M., Goronzy J.J. Arterial wall injury in giant cell arteritis. Arthritis Rheum. 42(5):1999;844-853
5. Weyand C.M., Goronzy J.J. Pathogenic principles in giant cell arteritis. Int. J. Cardiol. 75(Suppl. 1):2000;S9-S15. (Discussion S17-S19)
6. Hayreh S.S., Podhajsky P.A., Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am. J. Ophthalmol. 125(4):1998;521-526
7. Ghanchi F.D., Dutton G.N. Current concepts in giant cell (temporal) arteritis. Surv. Ophthalmol. 42(2):1997;99-123
8. Liu G.T., et al. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology. 101(11):1994;1779-1785
9. Font C., et al. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br. J. Rheumatol. 36(2):1997;251-254
10. Hoffman G.S., et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 46(5):2002;1309-1318
11. Albert D.M., Ruchman M.C., Keltner J.L. Skip areas in temporal arteritis. Arch. Ophthalmol. 94(12):1976;2072-2077
12. Grunewald J., et al. CD4+ and CD8+ T cell expansions using selected TCR V and J gene segments at the onset of giant cell arteritis. Arthritis Rheum. 37(8):1994;1221-1227
13. Martinez-Taboada V., et al. Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis. J. Mol. Med. 74(11):1996;695-703
14. Weyand C.M., Goronzy J.J. Giant cell arteritis as an antigen-driven disease. Rheum. Dis. Clin. North Am. 21(4):1995;1027-1039
15. Andersson R., et al. T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis. Ann. Rheum. Dis. 46(12):1987;915-923
16. Elling P., Olsson A.T., Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J. Rheumatol. 23(1):1996;112-119
17. Salvarani C., et al. Detection of parvovirus B19 DN by polymerase chain reaction in giant cell arteritis: a case-control study. Arthritis Rheum. 46(11):2002;3099-3101
18. Wagner A.D., Goronzy J.J., Weyand C.M. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. J. Clin. Invest. 94(3):1994;1134-1140
19. Weyand C.M., et al. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J. Clin. Invest. 98(7):1996;1642-1649
20. Weyand C.M., et al. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J. Exp. Med. 179(3):1994;951-960
21. Hoffman G.S. Large-vessel vasculitis: unresolved issues. Arthritis Rheum. 48(9):2003;2406-2414
22. Wagner A.D., et al. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum. 43(7):2000;1543-1551
23. Helweg-Larsen J., et al. No evidence of Parvovirus B19, Chlamydia pneumoniae or human herpesvirus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford). 41(4):2002;445-449
24. Mitchell B.M., Font R.L. Detection of varicella zoster virus DNA in some patients with giant cell arteritis. Invest. Ophthalmol. Visual Sci. 42(11):2001;2572-2577
25. Nordborg C., et al. Search for varicella zoster virus in giant cell arteritis. Ann. Neurol. 44(3):1998;413-414
26. Haugeberg G., Bie R., Nordbo S.A. Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen. J. Rheumatol. 28(7):2001;1738-1739
27. Haugeberg G., Bie R., Nordbo S.A. Chlamydia pneumoniae not detected in temporal artery biopsies from patients with temporal arteritis. Scand. J. Rheumatol. 29(2):2000;127-128
28. Regan M.J., et al. Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis Rheum. 46(4):2002;1056-1060
29. Michiels L., et al. Representational difference analysis using minute quantities of DNA. Nucleic Acids Res. 26(15):1998;3608-3610
30. Altschul S.F., Gish W. Local alignment statistics. Methods Enzymol. 266:1996;460-480
31. Guan K.L., Dixon J.E. Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 192(2):1991;262-267
32. Dalwadi H., et al. The Crohn's disease-associated bacterial protein I2 is a novel enteric T cell superantigen. Immunity. 15(1):2001;149-158
33. Eggena M., et al. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J. Autoimmun. 14(1):2000;83-97
34. Gordon L.K., et al. pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J. Clin. Immunol. 18(4):1998;264-271
35. Stempel D., et al. BetaB1-crystallin: identification of a candidate ciliary body uveitis antigen. Invest. Ophthalmol. Visual Sci. 44(1):2003;203-209
36. Gordon L.K., et al. Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies. Clin. Immunol. 94(1):2000;42-50
37. Wei B., et al. Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody. Infect. Immun. 69(10):2001;6044-6054
38. Stevens T.L., et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature. 334(6179):1988;255-258
39. Chakravarty K., Merry P. Systemic vasculitis and atypical infections: report of two cases. Postgrad. Med. J. 75(887):1999;544-546
40. Murakami K., et al. Large-vessel arteritis associated with chronic active Epstein-Barr virus infection. Arthritis Rheum. 41(2):1998;369-373
41. Ban S., et al. Systemic granulomatous arteritis associated with Epstein-Barr virus infection. Virchows Arch. 434(3):1999;249-254
42. Gabriel S.E., et al. The role of Parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum. 42(6):1999;1255-1258
43. Gilden D.H., et al. Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5 - 1995 revisited. Neurology. 47(6):1996;1441-1446
44. Rodriguez-Pereira C., et al. Cutaneous granulomatous vasculitis after herpes zoster infection showing polyarteritis nodosa-like features. Clin. Exp. Dermatol. 22(6):1997;274-276
45. Weck K.E., et al. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat. Med. 3(12):1997;1346-1353
46. Tanaka S., et al. Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J. Vasc. Surg. 20(2):1994;235-243
47. Yonemitsu Y., et al. In situ detection of frequent and active infection of human Cytomegalovirus in inflammatory abdominal aortic aneurysms: possible pathogenic role in sustained chronic inflammatory reaction. Lab. Invest. 74(4):1996;723-736
48. Dangler C.A., et al. Murine cytomegalovirus-associated arteritis. Vet. Pathol. 32(2):1995;127-133
49. Vardy S.J., Rose G.E. Orbital disease in herpes zoster ophthalmicus. Eye. 8(Pt. 5):1994;577-579
50. Kumano Y., et al. Detection of varicella-zoster virus genome having a PstI site in the ocular sample from a patient with acute retinal necrosis. Ophthalmic Res. 27(5):1995;310-316
51. Petursdottir V., et al. The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology (Oxford). 38(12):1999;1208-1212
52. Comer J.A., Paddock C.D., Childs J.E. Urban zoonoses caused by Bartonella, Coxiella, Ehrlichia, and Rickettsia species. Vector Borne Zoonotic Dis. 1(2):2001;91-118
53. Ko J., Splitter G.A. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16(1):2003;65-78
54. DelVecchio V.G., et al. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc. Natl. Acad. Sci. U. S. A. 99(1):2002;443-448
55. Tsolis R.M. Comparative genome analysis of the alpha-proteobacteria: relationships between plant and animal pathogens and host specificity. Proc. Natl. Acad. Sci. U. S. A. 99(20):2002;12503-12505
56. Finan T.M., Gough C., Truchet G. Similarity between the Rhizobium meliloti fliP gene and pathogenicity-associated genes from animal and plant pathogens. Gene. 152(1):1995;65-67
57. Lopez-Goni I., et al. Regulation of Brucella virulence by the two-component system BvrR/BvrS. Vet. Microbiol. 90(1-4):2002;329-339
58. Kempf V.A., et al. Do plant and human pathogens have a common pathogenicity strategy? Trends Microbiol. 10(6):2002;269-275
59. Greub G., Raoult D. Bartonella: new explanations for old diseases. J. Med. Microbiol. 51(11):2002;915-923
60. Roop I.R., et al. Brucella stationary phase gene expression and virulence. Annu. Rev. Microbiol. 2003
61. Relman D.A. New technologies, human-microbe interactions, and the search for previously unrecognized pathogens. J. Infect. Dis. 186(Suppl. 2):2002;S254-S258